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Receptor-Mediated Targeting of Magnetic
Nanoparticles Using Insulin as a Surface Ligand to
Prevent Endocytosis
Ajay Kumar Gupta*, Catherine Berry, Mona Gupta, and Adam Curtis
Abstract—Superparamagnetic iron oxide nanoparticles have
been used for many years as magnetic resonance imaging contrast
agents or in drug delivery applications. Tissue and cell-specific
drug targeting by these nanoparticles can be achieved by em-
ploying nanoparticle coatings or carrier-drug conjugates that
contain a ligand recognized by a receptor on the target cell. In this
study, superparamagnetic iron oxide nanoparticles with specific
shape and size have been prepared and coupled to insulin for
their targeting to cell expressed surface receptors and thereby
preventing the endocytosis. The influence of these nanoparticles
on human fibroblasts is studied using various techniques to
observe cell–nanoparticle interaction that includes light, scanning,
and transmission electron microscopy studies. The derivatization
of the nanoparticle surface with insulin-induced alterations in
cell behavior that were distinct from the underivatized nanopar-
ticles suggests that cell response can be directed via specifically
engineered particle surfaces. The results from cell culture studies
showed that the uncoated particles were internalized by the
fibroblasts due to endocytosis, which resulted in disruption of
the cell membrane. In contradiction, insulin-coated nanoparticles
attached to the cell membrane, most likely to the cell-expressed
surface receptors, and were not endocytosed. The presence of
insulin on the surface of the nanoparticles caused an apparent
increase in cell proliferation and viability. One major problem
with uncoated nanoparticles has been the endocytosis of particles
leading to irreversible entry. These results provide a route to
prevent this problem. The derivatized nanoparticles show high
affinity for cell membrane and opens up new opportunities for
magnetic cell separation and recovery that may be of crucial
interest for the development of cellular therapies.
Index Terms—Biological cells, drug delivery systems, magnetic
materials, nanotechnology.
I. INTRODUCTION
SUPERPARAMAGNETIC iron oxide nanoparticles withtailored surface chemistry have been widely used experi-
mentally for numerous in vivo applications such as magnetic
resonance imaging (MRI) contrast enhancement, tissue repair,
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immunoassay, detoxification of biological fluids, hyperthermia,
drug delivery, cell separation, etc. [1]–[4]. All these biomedical
and bioengineering applications require that these nanopar-
ticles have high magnetization values and size smaller than
20 nm with overall narrow particle size distribution so that
the particles have uniform physical and chemical properties.
In addition, these applications need special surface coating of
the magnetic particles, which has to be not only nontoxic and
biocompatible but also allow a targetable delivery with particle
localization in a specific area [5].
Cell labeling with ferro/paramagnetic substances is an in-
creasingly common method for in vivo cell separation [6], as
the labeled cells can be detected by MRI [7]. Most current la-
beling techniques utilize either of two approaches: 1) attaching
magnetic particles to the cell surface [8] or 2) internalizing bio-
compatible magnetic particles by fluid phase endocytosis [9],
receptor-mediated endocytosis [10], or phagocytosis [11]. One
strategy to realize efficient and specific cell labeling of mag-
netic particles is to modify the nanoparticle surface with a ligand
that is efficiently taken up by target cells via receptor-mediated
endocytosis [10]. A variety of potential ligands have been con-
jugated to nanoparticle surfaces to facilitate receptor-mediated
endocytosis of the particles, including monoclonal antibodies
(mabs) [11]. Targeting agents such as transferrin, lactoferrin,
albumin, insulin, growth factors, etc., have been demonstrated
to preferentially target cell surface, because the receptors for
these ligands are frequently overexpressed on the surface of
mammalian cells [12], [13]. These receptors are not only cel-
lular markers, but also have been shown to efficiently internalize
molecules coupled to these receptors [12]. Furthermore, many
of these ligands are stable and generally poorly immunogenic.
Despite the well-known ability of these receptors to facilitate
internalization of nanoparticles, little effort has been made on
delivery of magnetic nanoparticles modified with such ligands.
Superparamagnetic iron oxide nanoparticles of narrow size
range can be easily produced and coupled to proteins, thus pro-
viding convenient, readily targetable MRI agents. In this study,
magnetic iron oxide nanoparticles coated with insulin have been
prepared for exact delivery of drugs to target tissues. The in-
fluence of these nanoparticles on human dermal fibroblasts in
vitro has been assessed, as compared to those underivatized par-
ticles, in terms of cell adhesion, cytotoxicity, light microscopy,
scanning electron microscopy (SEM), and transmission elec-
tron microscopy (TEM). From the results, we observed that
insulin-derivatized superparamagnetic iron oxide nanoparticles
are targeted at the surface of the fibroblasts and, thus, may serve
as a nontoxic and improved way of drug targeting.
1536-1241/03$17.00 © 2003 IEEE
256 IEEE TRANSACTIONS ON NANOBIOSCIENCE, VOL. 2, NO. 4, DECEMBER 2003
II. MATERIAL AND METHODS
A. Materials
All the chemicals were of reagent grade and were used
without further purification. Ferric chloride hexahydrate
FeCl H O 99 , ferrous chloride tetrahydrate
FeCl H O , 1-Ethyl-3-(3-dimethylaminopropyl)-carbodi-
imide (EDCI), (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide) MTT, and insulin (human recombinant,
pH 8.2, 10mg/ml) were obtained from Sigma (Dorset, U.K.)
while sodium hydroxide NaOH and hydrochloric
acid HCl v/v were obtained from Fluka, Dorset,
U.K. Double distilled water was used for all the experiments.
B. Synthesis of Magnetic Nanoparticles
The ferric and ferrous salts (molar ratio 2 : 1) were dissolved
in deoxygenated water at a concentration of 0.1 M of iron ions.
Chemical precipitation was achieved by using a 1-M deoxy-
genated solution of sodium hydroxide. The reaction was carried
out in nitrogen atmosphere at low temperature (4 C–6 C) with
vigorous stirring. Particles were washed by dialysis using 12-kD
cutoff dialysis membrane against double distilled water to re-
move unreacted water salts. They were then precipitated with
acetone and dried in a vacuum oven at 70 C–80 C. The surface
of the particles was neutralized with 0.01-M HCl. A solution of
IM sodium oleate was added to form the stable dispersion of the
magnetite nanoparticles. To the aqueous suspension of magnetic
particles, sodium oleate solution was added dropwise with con-
tinuous and vigorous stirring at 60 C–70 C under nitrogen at-
mosphere. Excess sodium oleate was removed through rigorous
dialysis using 12-kD cutoff dialysis membrane as above.
C. Derivatization of Magnetic Particles With Insulin
Insulin was coupled covalently at the nanoparticle surface
by using 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide
(EDCI) coupling methods. Magnetic nanoparticles (10 mg/ml)
were suspended in 2-ml phosphate buffer pH 4.5 with
vortexing. To this solution a freshly prepared EDCI solution
(2% w/v in phosphate buffer, pH-4.5) was added dropwise
with shaking. The mixture was allowed to stir at room tem-
perature for 3-4 h. The particles were then washed twice
by centrifugation at 10 000 r/min followed by resuspension
in phosphate buffer. Finally, particles were centrifuged and
resuspended in borate buffer (pH-8.5). About 300–400 g
of the protein insulin [2 mg/ml in phosphate-buffered saline
(PBS) , pH 7.4] was then added and mixed gently overnight at
room temperature on an end-to-end mixer. The solution was
then centrifuged for 10 min at 10 000 r/min. The supernatant
was used for protein determination. Amount of protein coupled
was determined using Lowry’s method (BIO-RAD DC protein
assay kit, Hercules, CA) by calculating the difference between
the total amount of protein added and the amount present in the
supernatant. The particles were finally washed with water and
kept for future use.
D. Cell Culture
Infinity telomerase-immortalized primary human fibroblasts
(hTERT-BJ1, Clonetech Laboratories, Inc., Hampshire, U.K.)
were seeded onto 13-mm glass coverslips in a 24-well plate at
a density of 1 10 cells per well in 1 ml of complete medium
for 24 h, after which the growth medium was removed and
replaced with the medium containing nanoparticles. For control
experiments, medium with no particles was used. The medium
used was 71% Dulbecco’s modified Eagle’s medium (DMEM)
(Sigma, Dorset, U.K.), 17.5% Medium 199 (Sigma, Dorset,
U.K.), 9% fetal calf serum (FCS) (Life Technologies, Paisley,
U.K.), 1.6% 200 mM L-glutamine (Life Technologies, Paisley,
U.K.), and 0.9% 100 mM sodium pyruvate (Life Technologies,
Paisley, U.K.). The cells were incubated at 37 C in a 5% CO
atmosphere.
E. Cell Adhesion Assay
The effect of nanoparticles on cell adhesion was determined
with cell suspension incubated with or without nanoparticles.
Fibroblasts (h-TERT BJ1) were expanded in monolayer tissue
culture. The cells were detached using trypsin-EDTA solution
and divided into two individual populations. Cells were seeded
with or without nanoparticles at concentration 0.1 mg/ml for 24
h onto coverslips (13-mm diameter; in triplicate) at 37 C in
5% CO . The cells were washed twice with PBS, fixed in 4%
formaldehyde/PBS (15 min, 37 C), washed with PBS again,
and finally stained for 2 min in 1.0% Coomassie blue in acetic
acid/methanol mixture at room temperature. The adherent cells
were counted in three separate fields under a light microscope
using an eyepiece. The stained samples were observed by light
microscopy, and digital images of the fibroblasts were captured
using a Hamamatsu Argus 20 for image processing.
F. Live–Dead Assay for Cell Viability
Live–dead cell viability assay is a two-color fluorescence
assay that is based on the simultaneous determination of the
numbers of live and dead cells. Live cells have intracellular
esterases that converts nonfluorescent, cell permeable calcein
acetoxymethyl (calcein AM) to the intensely fluorescent green
calcein which is retained within the cells. On the other hand,
ethidium homodimer enters the damaged membranes of dead
cells and is fluorescent red when bound to nucleic acids. The
fibroblast cells were seeded onto 13-mm glass coverslips at
10 000 cells/ml in a 24-well tissue culture plate. After the cells
were attached to the coverslips, cell medium was exchanged
with the fresh medium containing nanoparticles and cells
were cultured at 37 C. After 24 hours, medium was removed
and the cells were washed with PBS followed by viability
staining using calcein AM (2 M, Molecular Probes, Leiden,
The Netherlands) and ethidium homodimer (4 , Molecular
Probes, Leiden, The Netherlands) for 1 h at room temperature.
All samples were viewed on a fluorescence microscope.
G. In Vitro Cell Viability/Cytotoxicity Studies
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetra-zolium bromide) assay is a simple nonradioactive
colorimetric assay to measure cell cytotoxicity, proliferation,
or viability. MTT is a yellow, water-soluble tetrazolium salt.
Metabolically active cells are able to convert this dye into
a water-insoluble dark-blue formazan by reductive cleavage
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of the tetrazolium ring [14]. Formazan crystals, then, can be
dissolved in an organic solvent such as dimethylsulphoxide
(DMSO) and quantified by measuring the absorbance of the
solution at 550 nm, and the resultant value is related to the
number of living cells. To determine cell cytotoxicity/viability,
the cells were plated at a density of 1 10 cells/well in a
96-well plate at 37 C in 5% CO atmosphere. After 24 h of
culture, the medium in the wells was replaced with the fresh
medium containing nanoparticles in varying concentrations.
After 24 h, 20 l of MTT dye solution (5 mg/ml in phosphate
buffer pH 7.4, MTT Sigma, Dorset, U.K.) was added to each
well. After 4 h of incubation at 37 C and 5% CO for expo-
nentially growing cells and 15 min for steady-state confluent
cells, the medium was removed and formazan crystals were
solubilized with 200 l of DMSO, and the solution was vig-
orously mixed to dissolve the reacted dye. The absorbance of
each well was read on a microplate reader (Dynatech MR7000
instruments) at 550 nm. The spectrophotometer was calibrated
to zero absorbance, using culture medium without cells. The
relative cell viability (%) related to control wells containing
cell culture medium without nanoparticles was calculated by
100.
H. Scanning Electron Microscopy of Cell Morphology
The cells were fixed with 1.5% glutaraldehyde (Sigma,
Dorset, U.K.) buffered in 0.1 M sodium cacodylate (Agar,
Stansted, U.K.) (4 C,1 h) after a 24-h incubation period to
allow the viewing of individual cells. The cells were then
postfixed in 1% osmium tetroxide (Agar, Stansted, U.K.), and
1% tannic acid (Agar, Stansted, U.K.) was used as a mor-
danant. Samples were dehydrated through a series of alcohol
concentrations (20%, 30%, 40%, 50%, 60%, 70%) followed
by further dehydration (90%, 96%, 100%, and dry alcohol).
The final dehydration was in hexamethyldisilazane (HMDS)
(Sigma, Dorset, U.K.), followed by air-drying. Once dry, the
samples were sputter coated with gold before examination with
a Phillips SEM 500 field emission SEM at an accelerating
voltage of 12 kV.
I. Transmission Electron Microscopy
Cells were incubated with nanoparticle solutions for 24 h as
discussed before. Cells were fixed as for SEM studies, stained
for 60 min with 1% osmium tetroxide and then taken directly
through the alcohol steps up to dried absolute alcohol. The
cells were finally treated with propylene oxide followed by 1 : 1
propylene oxide : resin for overnight to evaporate the propylene
oxide. The cells were subsequently embedded in Spur’s resin,
and ultrathin sections were cut and stained with lead nitrate and
viewed under a Zeiss 902 electron microscope at 80 kV.
J. Statistical Analysis
The statistical analysis of experimental data utilized the stu-
dent’s t-test, and the results were presented as mean stan-
dard deviations. Statistical significance was accepted at a level
of 0.05.
Fig. 1. Graphical representation of number of cells adhered, when incubated
with uncoated plain, and insulin-coated particles onto glass coverslips, after
24-h culture as compared to controls (results are represented as mean standard
deviations; n = 3, counted in triplicate in individual microscope fields).
III. RESULTS
The magnetic nanoparticles were synthesized by coprecipita-
tion of ferrous and ferric salts solution by concentrated sodium
hydroxide solution and characterized as reported previously
[15]. Amount of protein bound to the nanoparticles was de-
termined by Lowry’s method and calculated by the difference
between the total amount of protein added and the amount
present in the supernatant. The percentage of protein binding to
nanoparticles by two-step EDCI coupling process was found to
be around 60% of the total protein added initially for binding.
The effect of incubating cells with nanoparticles on cell ad-
hesion to glass coverslips, as compared to control cells (without
particles), was determined, and the results are shown in Fig. 1.
It was observed that insulin coating on nanoparticle surfaces
gives rise to changes in adhesion capacity of the fibroblasts
on glass. The figure shows that the number of attached cells
was decreased significantly, up to 53% in the case of uncoated
plain nanoparticles compared to the corresponding control cell
number (no particle). Growing the cells with insulin-coated
samples produced no significant difference compared to that of
control cell population.
The general morphology of the fibroblasts incubated with
nanoparticles after staining with Coomassie blue is shown in
Fig. 2. The figure shows that the cells were well spread, and
there was no distinct change in morphology after 24-h incuba-
tion with insulin-coated particles relative to control cells. But
the cells grown in the presence of uncoated plain nanoparticles
were found to be less spread with altered cell morphology pos-
sibly due to endocytosis of particles. Cell viability staining using
calcein AM/ethidium homodimer showed that the cells exposed
to insulin-coated nanoparticles were more than 99% viable.
The MTT assay for cell viability evaluation has been de-
scribed as a very suitable method for detection of biomaterial
toxicity [14]. The MTT assay relies on the mitochondrial
activity of fibroblasts and represents a parameter for their
metabolic activity. The proliferation/viability of fibroblasts was
measured by MTT assay after culturing for 24 h, and it showed
that cell proliferation was more favorable in case of pro-
tein-coated particles than with uncoated ones. Insulin-coated
nanoparticles revealed no cytotoxic effects to cells, and
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Fig. 2. Coomassie blue stained cells incubated with different magnetic
particles for 24 h at 37 C. (a) Control. (b) Uncoated. (c) Insulin-coated
nanoparticles; (n = 3).
they remained more than 100% viable relative to control at
concentration as high as 1mg/ml, as shown in Fig. 3. The
increased cell viability can be explained by nutrient effect [16].
Plain uncoated nanoparticles affected the metabolic activity in
concentration dependent manner when they were added in the
concentration range of 0–1000 g/ml to the cells. Cytotoxicity
of the nanoparticles increased in relation to increasing con-
Fig. 3. Cytotoxicity profiles of magnetic nanoparticles when incubated
with human fibroblasts as determined by MTT assay. Percentage of viability
of fibroblasts was expressed relative to control cells (n = 6). Results are
represented as mean  standard deviations.
centration. Incubation with uncoated plain magnetic particles,
the fibroblasts showed significant loss in viability of about
25%-50% observed at concentrations 250 g/ml. Below this
concentration, cellular metabolic activity did not change much
in comparison with control cells.
SEM images taken at 24 h provided further information on
cell morphology in response to particle incubation. It was ob-
served from the SEM results (Fig. 4) that the control cells are
flat and well spread with small lamellapodia, suggesting cell
motility. Insulin-coated nanoparticles appeared to localize and
adhere to the cell surface as demonstrated in the figure. Plain un-
coated particles were found to be endocytosed by the cells. The
fibroblasts exhibited vacuoles in the cell body with cell mem-
brane abnormalities. In addition, cells were less spread, small in
shape, and stimulated the formation of many lamellapodia and
filopodia, observed projecting from the cell membranes over the
glass surface.
The results obtained from light microscopy and SEM studies
were confirmed with TEM studies, as shown in Fig. 5. The pic-
tures showed that the uncoated plain magnetic nanoparticles are
internalized within the fibroblast as a result of endocytosis. Sev-
eral electron lucent voids containing nanoparticles can be seen
in the cytoplasm of the fibroblasts forming the vacuoles. The
cellular burden of the particles was often so great that much of
the cell area was compromised of nanoparticles. It is apparent
from the pictures that surface derivatization with insulin made
the nanoparticles strongly cell surface adhesive, and the parti-
cles could be seen on the surface of the fibroblasts with no par-
ticle internalization.
IV. DISSCUSSION
Insulin was coupled to the nanoparticle surfaces to preferen-
tially target the human fibroblasts that have the receptors for
these proteins expressed on their surface. The derivatization of
insulin on the nanoparticles was carried out using a two-step
EDCI coupling procedure without affecting the colloidal sta-
bility of the ferrofluids.
Nanoparticle–cell interaction depends on the surface aspects
of materials, which may be described according to their chem-
istry, hydrophilic/hydrophobic characteristics or surface energy.
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Fig. 4. SEM pictures of human fibroblasts incubated with magnetic nanoparticles. (a) Control cells. (b) Plain uncoatd particles. (c) and (d) Insulin-coated
nanoparticles. The pictures shows that insulin-coated nanoparticles adhere to the cell surface whereas plain uncoated particles were found to be endocytosed
by the cells.
These surface characteristics determine how the nanoparticles
will adsorb to the cell surface and more particularly determine
the cell behavior on contact. Cells in the presence of nanoparti-
cles first attach, adhere, and spread on the surfaces. Thereafter,
the quality of cell adhesion will influence their morphology
and their capacity for proliferation and differentiation [17]. It
is known that cell adhesion is mediated by the interaction of
surface proteins such as integrins with proteins in the extracel-
lular matrix or on the surface of other cells or particles. The phe-
nomenon of cell adhesion is of crucial importance in governing
a range of cellular functions including cell growth, migration,
differentiation, survival, and tissue organization [17].
It was observed from cell culture studies that the plain un-
coated nanoparticles reduced cell adhesion and viability signif-
icantly as compared to the cells that were not exposed to the
nanoparticles. One possible explanation for this large decrease
in cell adhesion and viability is that these nanoparticles are taken
up by the cells as a result of endocytosis or are promoting apop-
tosis (programmed cell death) due to weak cell adhesive inter-
actions with the nanoparticles. The low toxicity of nanoparticles
derivatized with insulin may be attributed to the fact that these
ligands act as cellular markers that are targeted at the surface
receptors expressed on the cell surface without being internal-
ized. Receptors are highly regulated cell surface proteins, which
mediate specific interactions between the cells and their extra-
cellular milieu and they are generally localized on the plasma
membrane.
The SEM studies also verified the above results. These studies
showed that the each nanoparticle type with different surface
characteristics caused a distinct cell response. The uncoated par-
ticles were endocytosed by the fibroblasts during the 24-h incu-
bation, thereby causing cell death possibly through apoptosis
due to the internalization [18]. Endocytosis of the particles re-
sulted in disruption of the cell membrane. Cells were found to
be less spread, small in size, and stimulated the formation of
many lamellipodia and filopodia, observed projecting from cell
membranes over the glass surface. From SEM studies, it could
be seen that insulin-derivatized particles are highly adhesive to
the cell surface receptors.
Phagocytosis involves uptake of extracellular cargo that is
generally larger than 500 nm, otherwise, uptake is due to the
endocytosis or pinocytosis. Upon endocytosis the particles may
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Fig. 5. TEM prictures of human fibroblasts incubated with nagnetic nanoparticles. (a) Control. (b) Plain uncoated. (c) Insulin-coated magnetic nanoparticles.
result in the formation of the vacuoles in the cell body and ex-
tended cell membrane protrusions [19]. From SEM and light
microscopy results, we observed that the surface functionalized
particles did not change the cell morphology to a greater ex-
tent as compared to uncoated ones. The TEM studies indicated
that a substantial number of uncoated particles were internalized
by the cells, confirming the above SEM and light microscopy
studies. It was also concluded from the TEM pictures that the
insulin-derivatized particles are not internalized but found to ad-
here at the cell surface.
In the absence of any system to inhibit endocytosis, most
underivatized nanoparticles are endocytosed by cells and even-
tually sequestered in digestive vacuoles in the cell. Once the par-
ticles are endocytosed, they are probably removed from contact
with specific cell surface receptors and become effectively in-
effective. As a result of these events, the cells are at high risk
of apoptosis from overload with particles. If the particles can be
prevented from leaving the cell surface, they will remain in con-
tact with their specific receptors and would be expected to leave
the cell in a state of prolonged stimulation while protecting the
cells from side effects due to endocytosis. In the present study,
we have discovered a route to derivatising superparamagnetic
nanoparticles with various proteins that bind strongly to surface
receptors that phagocytosis is inhibited. Confinement to the cell
surface would provide a route that might allow removal of the
particles from the cells after an appropriate residence time.
V. CONCLUSION
Superparamagnetic nanoparticles with distinct surface
characteristics induces either endocytosis or adhesion to the
cell membrane. Both types of response could provide routes
of investigation with regards to drug delivery techniques.
Surface functionalized nanoparticles with insulin showed high
affinity for cell surface receptor mainly due to ligand–receptor
interactions. Their specific attachment to cell surface offers
the opportunity to label the cells with magnetic particles while
reducing nonspecific phagocytosis. This type of directed action
would prove useful in drug delivery to specific cell types
without causing any harmful effects to healthy cells. For drug
delivery systems where cell death is required, as in the case of
cancer cells, the uncoated particles may prove useful.
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